...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.
【24h】

Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.

机译:趋化因子受体在鼻咽癌中的表达谱及其与转移和放疗的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Nasopharyngeal carcinoma (NPC) is an epithelial cancer that metastasizes predictably to cervical lymph nodes or distant organs. To assess whether the chemokine receptors of NPC cells play important roles in metastasis and are associated with radiotherapy history, the significance of various chemokine receptors (CCR1-10, CXCR1-6, XCR1, and CX3CR1) in NPC cell lines (TW01, TW04, HONE1, BM1, and AS1) and 52 NPC tumour biopsies from 48 patients with NPC was evaluated by mRNA and cytometric analyses, chemotaxis and actin polymerization assays, and immunohistochemical staining. Quantitative real-time reverse transcription-polymerase chain reaction revealed substantial expression of CCR7, CCR9, CXCR4, and CXCR6 mRNA in all the NPC cell lines. Of these, however, only CCR7, CXCR4, and CXCR6 were functional in NPC cells. Negative immunoreactivity for CCR7, CXCR4, and CXCR6 was demonstrated in almost all nasopharyngeal (NP) specimens from patients with primary NPC (n = 12) and in those with regional metastatic NPC (n = 15). However, expression of two or three of these chemokine receptors was demonstrated in NP specimens from patients with liver metastasis. Strong positivity was demonstrated for all three of these chemokine receptors in almost all of the regional and distant metastasis specimens. Significant differences in the expression of CCR7, CXCR4, and CXCR6 were found between primary tumours and metastases (p < 0.001, p < 0.001, and p < 0.002, respectively). This observation was further confirmed by laser capture microdissection of freshly frozen tumours from primary (n = 5) and metastatic (n = 8) NPC sites (p = 0.04, 0.03, and 0.03 for CCR7, CXCR4, and CXCR6, respectively). Finally, significant differences in CXCR4 expression were demonstrated between de novo and post-radiotherapy groups (1/22 vs. 5/8; p < 0.003). It appears reasonable to conclude, therefore, that CCR7, CXCR4, and CXCR6 are expressed and active in human NPC metastases, while CXCR4 expression is associated with radiotherapy history.
机译:鼻咽癌(NPC)是一种上皮癌,可预测地转移至宫颈淋巴结或远处器官。为了评估NPC细胞的趋化因子受体在转移中是否起重要作用并与放疗史相关,NPC细胞系(TW01,TW04,NPC)中各种趋化因子受体(CCR1-10,CXCR1-6,XCR1和CX3CR1)的意义通过mRNA和细胞计数分析,趋化性和肌动蛋白聚合分析以及免疫组化染色评估了48例NPC患者的HONE1,BM1和AS1)和52例NPC肿瘤活检。实时定量逆转录聚合酶链反应显示在所有NPC细胞系中CCR7,CCR9,CXCR4和CXCR6 mRNA大量表达。但是,其中只有CCR7,CXCR4和CXCR6在NPC细胞中起作用。在患有原发性鼻咽癌的患者(n = 12)和具有区域转移性鼻咽癌的患者(n = 15)的几乎所有鼻咽(NP)标本中,CCR7,CXCR4和CXCR6的免疫反应均为阴性。但是,在来自肝转移患者的NP标本中证实了这些趋化因子受体中的两种或三种表达。在几乎所有的区域和远处转移标本中,对所有这三种趋化因子受体均显示出强阳性。在原发性肿瘤和转移瘤之间发现了CCR7,CXCR4和CXCR6表达的显着差异(分别为p <0.001,p <0.001和p <0.002)。通过从原发性(n = 5)和转移性(n = 8)NPC部位(CCR7,CXCR4和CXCR6的p分别为0.04、0.03和0.03)的新鲜冷冻肿瘤的激光捕获显微解剖进一步证实了这一观察结果。最后,从头开始和放射治疗后的组之间证实了CXCR4表达的显着差异(1/22对5/8; p <0.003)。因此,可以得出合理的结论:CCR7,CXCR4和CXCR6在人NPC转移中表达并具有活性,而CXCR4的表达与放疗史相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号